83 results
8-K
EX-99.1
564ql45fcby
11 Oct 22
Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Active Customer Sites Increase 18% YoY
7:30am
8-K
0w619o5
13 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
gbto igzxrtbc6v42
13 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
uf2igozdhr75 l4v7t6k
14 Aug 20
Nephros Names Andy Astor President and Chief Executive Officer
4:15pm
8-K
nuu a92g6da7eq084lxh
31 Jan 20
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
10:44am
8-K
EX-99.1
poe9bjeg8
31 Jan 20
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
10:44am
8-K
EX-10.1
j58rp2
26 Dec 19
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
9vb68zd98w70 15
13 Aug 19
Nephros Announces Listing on Nasdaq Capital Market
7:45am
424B3
5pwfwo
25 Jun 18
Prospectus supplement
7:01am